Spotlight Series
Complimentary presentations, delivered by AHA experts at hospitals grand rounds nationwide, covering the newest, evidence-based measures to prevent cardiovascular disease, the #1 killer of men and women in the US.
Here’s an overview of the Spotlight Series:
Why: Educating your team on the latest science and guidelines can improve patient care and outcomes.
How: Spotlight Series offers free case-based presentations that give powerful evidence-based practices to your team.
Who: Physicians, nurses, pharmacists and other health care professionals.
When: You decide. We seek 45 days of lead time but will try to fulfill your request based on speaker availability.
Where: Anyplace you hold a hospital grand rounds type session.
What: Available topics for Spotlight Series appear below.
How: Spotlight Series offers free case-based presentations that give powerful evidence-based practices to your team.
Who: Physicians, nurses, pharmacists and other health care professionals.
When: You decide. We seek 45 days of lead time but will try to fulfill your request based on speaker availability.
Where: Anyplace you hold a hospital grand rounds type session.
What: Available topics for Spotlight Series appear below.
New Series Coming Soon!
Advancing Care in HFpEF & HFmrEF: Optimizing Therapies for Better Outcomes
Heart Failure with preserved ejection fraction (HFpEF) is a diverse syndrome often driven by conditions like hypertension, diabetes, obesity, and coronary or kidney disease. It is defined as heart failure with a LVEF (left ventricular ejection fraction) is ≥ 50% and accounting for more than 50% of all patients with heart failure. HFmrEF (mildly reduced ejection fraction) is diagnosed in patients with HF symptoms and LVEF between 41–49%.
Learning Objectives
- Recognize and discuss the high unmet clinical and societal burden of HFmrEF and HFpEF.
- Describe the importance of early initiation of proven treatment options to improve health outcomes and reduce residual risk for patients at risk for HF and with HF.
- Differentiate between non-steroidal MRAs and steroidal MRAs as treatment options for HFmrEF and HFpEF including mechanism of action, efficacy, and safety.
American Heart Association Professional Members
Enjoy instant benefits!
- Free Online Access to AHA Scientific Journals
- Affiliate with our 16 Scientific Councils
- Discounts on Scientific Conference Registration and Online Courses
